Clinical trial
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02061683 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
- Lead sponsor
- Allergan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 19, 2010
- Completion date
- June 24, 2011
- Enrollment
- 263 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.